If the first month at NYU Langone’s new Center for Musculoskeletal Care (CMC) is any indication of the growing need for integrated care, the more than 16,000 patients coming to the facility since it opened in April is a true testament.
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA).
Arthritis month highlights importance of clinical expertise, research and technology to aid in earlier identification of joint diseases, better long-term outcomes.
Throughout the month of May, the American College of Rheumatology, Arthritis Foundation, Mayo Clinic, and Nemours are partnering to celebrate Arthritis Action Month (formerly Arthritis Awareness Month).
Scientists led by Washington University School of Medicine in St. Louis have identified the first gene directly linked to the most common form of psoriasis, a chronic skin condition.
After losing her sister to an autoimmune disease almost 15 years ago, "Army Wives" star Kellie Martin will serve as AARDA's "Autoimmune Walk" Ambassador.
As baby boomers age, orthopedic surgeons are seeing more and more patients, especially women, who suffer from debilitating arthritis of the thumb.
A trend toward more aggressive treatment in patients just starting to develop rheumatoid arthritis is among the most important changes in treatment guidelines for the disease, according to updated American College of Rheumatology guidelines published in the journal Arthritis Care & Research.
• Metastases increased in mice with breast cancer and arthritis. • Mast cells one of the major underlying causes of metastases. • Therapies could be developed to decrease metastases.
A recent summit that brought together international multidisciplinary experts has provided a foundation for addressing what is the leading cause of disability in the United States: osteoarthritis.
When medications no longer work to relieve the pain of arthritis, joint replacement becomes a viable option, especially for many of today’s baby boomers and active middle-agers unwilling to trade in physical activity for a sedentary life.
Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.
Survey shows that infertiliy problems and pregnancy complications are much more common for women with rheumatoid arthritis or lupus .
A new study has demonstrated that a procedure wherein healthy cartilage is transplanted to fix an area of damaged cartilage is superior to the standard of care for repairing cartilage defects.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
As the number of knee and hip joint replacements grows, nanodiamond coatings could answer problems related to metal surfaces.
Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex® and Lipitor® -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.
A Boise State University study has shed new light on how proteins interact, or bind, with one another in tissues. Boise State biologists found that a protein called collagen XI interacts with specific proteins in the part of the tissue that provides structural support to the cell.
Steven R. Goldring, M.D., chief scientific officer, has been named the first Richard L. Menschel Research Chair at Hospital for Special Surgery. A gift of $5 million from an anonymous donor will permanently endow the position of the Hospital’s chief scientific officer.
Having both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand women who took part in a U.S. government-sponsored, multiyear national health study, and excluded women whose ovaries were removed due to cancer.
More than 270,000 Americans get hip replacement surgeries every year. With various options for implants, including metal-on-polyethylene, metal-on-metal and ceramic-on-ceramic, there have been questions about which kind works best. A new FDA-funded data analysis, the first of its kind, has found no clear advantage of one implant type over another in terms of effectiveness but presented evidence of a potential for harm associated with metal-on-metal implants.
Nutrition expert and oncologist at The Ohio State University join forces to study the efficacy of omega-3 fatty acids to mediate side effects of common breast cancer therapies. Inlcudes a review of in progress research, plus simple cooking and dietary tips for increasing omega-3 intake, plus omega-3 rich recipes for the holidays.
Steven B. Abramson, MD, professor, Departments of Medicine and Pathology at NYU Langone Medical Center received the Distinguished Basic Investigator Award at the American College of Rheumatology (ACR) annual scientific meeting this week in Chicago.
Hospital for Special Surgery physician-scientists who focus on arthritis, lupus, vasculitis and related conditions are traveling to Chicago this week to share recent findings at the 75th Annual Scientific Meeting of the American College of Rheumatology.
Compared with osteoarthritis patients, individuals with rheumatoid arthritis who undergo total knee replacement surgery have lower expectations about their postsurgical outcomes, according to a new study by researchers at Hospital for Special Surgery.
As guidelines recommend, doctors appear to be stopping anti-TNF medications before surgery, but may be doing so far sooner than is necessary, according to a new study by researchers at Hospital for Special Surgery.
Experts from NYU Langone Medical Center will present new research findings and clinical insight into the treatment of rheumatic and bone diseases in a variety of presentations at the American College of Rheumatology (ACR) 2011 Annual Scientific Meeting in Chicago, November 5-9, 2011.
American College of Rheumatology celebrates World Arthritis Day.
University of North Carolina at Chapel Hill scientists investigate a gene that appears to protect against rheumatoid arthritis. The research could inform future treatment approaches.
Medications known as disease-modifying anti-rheumatic drugs, or DMARDs, appear to be more effective than other treatments for children with arthritis.
Stomach acid-reducing drugs, known as proton pump inhibitors, may actually be aggravating damage in the small intestine caused by the nonsteroidal anti-inflammatory drugs, also known as NSAIDs.
As cloud computing becomes the next big consumer techo –trend, it’s also on the verge of revolutionizing the way research is done. Using the cloud model as inspiration, biomedical informatics scientists at The Ohio State University have created the Translational Research Informatics and Data management grid (TRIAD), a system which is helping researchers around the world access and analyze biomedical data at an unprecedented pace. Importantly, TRIAD enables researchers to anonymously match tissue samples with de-identified clinical data from medical records, maintaining the patient’s privacy rights while eliminating the time-intensive process of seeking additional approval for each individual study that does not require access to patient identifiers such as names, addresses, and medical record numbers.
Researchers from NYU Langone Medical Center’s Departments of Orthopaedic Surgery and Radiology found that advanced MRI techniques can be used to detect subtle changes in joint cartilage microstructure – and provide physicians a diagnostic tool for finding key markers of early osteoarthritis (OA).
A Mayo Clinic orthopedic surgeon suspects that the nagging pain and inflammation that women can experience in their knees may be different from what men encounter, and she has been chosen to lead a novel U.S.-Canadian study to explore the question.
For people with severe chronic pain, coping with agony is a fact of life. What patients need to know: finding a doctor, treatment options and facing pain while moving forward.
Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.
To provide orthopedic surgeons with the latest clinical data and opinions on topics related to treating young adults with hip pain, Hospital for Special Surgery, along with the University of Ottawa Faculty of Medicine, will co-host a symposium drawing on the expertise of professionals from around the world.
Experts offer updates on research and treatments for rheumatoid arthritis with leading online community advocates
Osteoarthritis affects 27 million Americans. In an effort to elucidate the latest information in diagnosis, treatment, research and prevention, Hospital for Special Surgery will host an international Osteoarthritis Summit June 17 and June 18.
A new study by rheumatologists at Hospital for Special Surgery has shown that a powerful pro-inflammatory protein, tumor necrosis factor (TNF), can also suppress aspects of inflammation.
By analyzing complex interactions of the immune system in an animal study, researchers have found potential tools for controlling a cytokine storm, a life-threatening condition that may strike children who have juvenile arthritis and other autoimmune diseases.
The American College of Rheumatology Research and Education Foundation today announced its Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign has surpassed its initial $30 million fundraising goal and has already funded $24.4 million in RA research grants.
A mechanical engineering professor at Michigan Tech is studying how the aging knee degenerates, in hopes of finding ways to prevent painful osteoarthritis.
The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal of broad acceptance within the rheumatology community.
Spondyloarthritis (SpA) is a group of inflammatory conditions causing spine and joint pain and deformity, mostly in young men. Important updates on the epidemiology, diagnosis, and treatment of SpA are presented in the April issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The rheumatology program at NewYork-Presbyterian Hospital/Columbia University Medical Center is expanding with the addition of one of the nation's leading rheumatologists, the creation of a new integrated Arthritis Center, and plans for additional disease-specific centers.
For years, doctors have used platelet-rich plasma, or PRP, to promote healing after surgery. Now, Rush University Medical Center is studying whether PRP can help relieve knee pain in patients with mild to moderate osteoarthritis.
Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
A comprehensive "prehabilitation" exercise program for patients with severe knee arthritis can improve strength and functional ability before knee replacement surgery, reports a study in the February issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Pluripotent stem cells have been generated from horses by a team of researchers. The findings will help enable new stem-cell based regenerative therapies in veterinary medicine, and because horses’ muscle and tendon systems are similar to our own, aid the development of preclinical models.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right